Zydus Lifesciences receives USFDA approval for Cyanocobalamin Injection

21 Apr 2022 , 01:32 AM

Zydus Lifesciences has received final approval from the USFDA to market Cyanocobalamin Injection in the strengths of 1000 mcgmL10000 mcg10 mL 1000 mcgmL and 30000 mcg30 mL 1000 mcgmL Multiple-Dose Vials US RLD Cyanocobalamin Cyanocobalamin injection is used to treat and prevent lack of vitamin B12 that may be caused due to pernicious anemia lack of a natural substance needed to absorb vitamin B12 from the intestine certain diseases infections or medications decrease the amount of vitamin B12 absorbed from food The drug will be manufactured at the groups injectables manufacturing facility at Jarod Gujarat The group now has 331 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04